Reckitt Benckiser Group PLC (RKT) - Total Liabilities
Based on the latest financial reports, Reckitt Benckiser Group PLC (RKT) has total liabilities worth GBX17.29 Billion GBX (≈ $2.10 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore RKT net assets growth trend to track the company's year-over-year net asset growth rate.
Reckitt Benckiser Group PLC - Total Liabilities Trend (2000–2025)
This chart illustrates how Reckitt Benckiser Group PLC's total liabilities have evolved over time, based on quarterly financial data. See Reckitt Benckiser Group PLC (RKT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reckitt Benckiser Group PLC Competitors by Total Liabilities
The table below lists competitors of Reckitt Benckiser Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Hollywave Electronic System Co. Ltd. A
SHG:688682
|
China | CN¥228.04 Million |
|
Seobu T&D Co. Ltd
KQ:006730
|
Korea | ₩1.80 Trillion |
|
Tokmanni Group Oyj
HE:TOKMAN
|
Finland | €1.19 Billion |
|
Solusi Bangun Indonesia Tbk PT
JK:SMCB
|
Indonesia | Rp7.00 Trillion |
|
SNT Motiv Co Ltd
KO:064960
|
Korea | ₩259.97 Billion |
|
Eik fasteignafélag hf
IC:EIK
|
Iceland | Ikr109.70 Billion |
|
Xinxiang Tuoxin Pharmaceutical Co.Ltd.
SHE:301089
|
China | CN¥176.07 Million |
|
Nanjing University Environmental
SHE:300864
|
China | CN¥500.44 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Reckitt Benckiser Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Reckitt Benckiser Group PLC.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Reckitt Benckiser Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Reckitt Benckiser Group PLC (2000–2025)
The table below shows the annual total liabilities of Reckitt Benckiser Group PLC from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX17.29 Billion ≈ $2.10 Million |
-6.95% |
| 2024-12-31 | GBX18.58 Billion ≈ $2.26 Million |
-0.48% |
| 2023-12-31 | GBX18.67 Billion ≈ $2.27 Million |
-3.07% |
| 2022-12-31 | GBX19.26 Billion ≈ $2.34 Million |
-1.20% |
| 2021-12-31 | GBX19.49 Billion ≈ $2.37 Million |
-11.93% |
| 2020-12-31 | GBX22.13 Billion ≈ $2.69 Million |
-2.64% |
| 2019-12-31 | GBX22.73 Billion ≈ $2.77 Million |
-0.56% |
| 2018-12-31 | GBX22.86 Billion ≈ $2.78 Million |
-2.47% |
| 2017-12-31 | GBX23.44 Billion ≈ $2.85 Million |
+144.34% |
| 2016-12-31 | GBX9.59 Billion ≈ $1.17 Million |
+14.72% |
| 2015-12-31 | GBX8.36 Billion ≈ $1.02 Million |
-3.46% |
| 2014-12-31 | GBX8.66 Billion ≈ $1.05 Million |
-1.71% |
| 2013-12-31 | GBX8.81 Billion ≈ $1.07 Million |
-3.77% |
| 2012-12-31 | GBX9.16 Billion ≈ $1.11 Million |
+9.74% |
| 2011-12-31 | GBX8.35 Billion ≈ $1.02 Million |
+0.64% |
| 2010-12-31 | GBX8.29 Billion ≈ $1.01 Million |
+78.44% |
| 2009-12-31 | GBX4.65 Billion ≈ $565.41K |
-21.08% |
| 2008-12-31 | GBX5.89 Billion ≈ $716.40K |
+69.05% |
| 2007-12-31 | GBX3.48 Billion ≈ $423.78K |
-10.02% |
| 2006-12-31 | GBX3.87 Billion ≈ $470.99K |
+64.23% |
| 2005-12-31 | GBX2.36 Billion ≈ $286.78K |
+3.74% |
| 2004-12-31 | GBX2.27 Billion ≈ $276.44K |
-3.15% |
| 2003-12-31 | GBX2.35 Billion ≈ $285.44K |
+1.82% |
| 2002-12-31 | GBX2.30 Billion ≈ $280.33K |
+5.83% |
| 2001-12-31 | GBX2.18 Billion ≈ $264.88K |
-0.55% |
| 2000-12-31 | GBX2.19 Billion ≈ $266.34K |
-- |
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil a… Read more